The Influence of the COVID-19 Pandemic on the Addressability to Treatment of Children with Hyperhidrosis—A Retrospective Study and a Short Review
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
- 1—indicate a mild or lack of hyperhidrosis,
- 2—indicate a moderate hyperhidrosis
- 3 and 4—indicate a severe hyperhidrosis.
5. Conclusions
- The pandemic restrictions have a significant impact on medical or dermatological diseases.
- The impact of the pandemic was manifested by a marked reduction in face-to-face dermatological consultations.
- The COVID-19 pandemic also left its mark on the addressability of treatment for patients with hyperhidrosis.
- The drop to 0 in patients’ presentation to perform iontophoresis per year demonstrates the impact of the pandemic on the choice to treat hyperhidrosis.
- There are two patients with hyperhidrosis who came to the Rehabilitation Department in 2021; it is important to highlight that the patients and their families came for other reasons, more urgent, and they performed iontophoresis, together with the specific rehabilitation program for back pain and humeral fracture status.
- There is also a drop to 0 in the addressability of the dermatologist for diagnosis and treatment.
- It must be realized that hyperhidrosis is a disease with a strong impact on children’s lives.
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Kamudoni, P.; Mueller, B.; Salek, M.S. The development and validation of a disease-specific quality of life measure in hyperhidrosis: The Hyperhidrosis Quality of Life Index (HidroQOL). Qual. Life Res. 2015, 24, 1017–1027. [Google Scholar] [CrossRef] [PubMed]
- Gibbons, J.P.; Nugent, E.; O’Donohoe, N.; Maher, B.; Egan, B.; Feeley, M.; Tierney, S. Experience with botulinum toxin therapy for axillary hyperhidrosis and comparison to modelled data for endoscopic thoracic sympathectomy—A quality of life and cost effectiveness analysis. Surgeon 2016, 14, 260–264. [Google Scholar] [CrossRef] [PubMed]
- Lopez-Lopez, D.; Becerro-de-Bengoa-Vallejo, R.; Losa-Iglesias, M.E.; Rodriguez-Sanz, D.; Palomo-Lopez, P.; Calvo-Lobo, C. Relationship between depression scores and degree of skin perspiration: A novel cross-sectional study. Int. Wound J. 2019, 16, 139–143. [Google Scholar] [CrossRef]
- Rieger, R.; Pedevilla, S.; Lausecker, J. Quality of Life After Endoscopic Lumbar Sympathectomy for Primary Plantar Hyperhidrosis. World J. Surg. 2015, 39, 905–911. [Google Scholar] [CrossRef] [PubMed]
- Kamudoni, P.; Mueller, B.; Halford, J.; Schouveller, A.; Stacey, B.; Salek, M.S. The impact of hyperhidrosis on patients’ daily life and quality of life: A qualitative investigation. Health Qual. Life Outcomes 2017, 15, 121. [Google Scholar] [CrossRef] [PubMed]
- Wolosker, N.; Schvartsman, C.; Krutman, M.; Pereira Donozo Almeida Campbell, T.; Kauffman, P.; de Campos, J.R.M.; Puech-Leao, P. Efficacy and Quality of Life Outcomes of Oxybutynin for Treating Palmar Hyperhidrosis in Children Younger than 14 Years Old. Pediatr. Dermatol. 2014, 31, 48–53. [Google Scholar] [CrossRef] [PubMed]
- De Nadai Dias, L.I.; Martins Miranda, E.C.; Contrera Toro, I.F.; Mussi, R.K. Relationship between anxiety, depression and quality of life with the intensity of reflex sweating after thoracoscopic sympathectomy for treatment of primary hyperhidrosis. Rev. Col. Bras. Cir. 2016, 43, 354–359. [Google Scholar] [CrossRef] [PubMed]
- Klein, S.Z.; Hull, M.; Gillard, K.K.; Peterson-Brandt, J. Treatment Patterns, Depression, and Anxiety Among US Patients Diagnosed with Hyperhidrosis: A Retrospective Cohort Study. Dermatol. Ther. 2020, 10, 1299–1314. [Google Scholar] [CrossRef]
- Solish, N.; Bertucci, V.; Dansereau, A.; Chih-Ho Hong, H.; Lynde, C.; Lupin, M.; Smith, K.C.; Storwick, G. A Comprehensive Approach to the Recognition, Diagnosis, and Severity-Based Treatment of Focal Hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol. Sur. 2007, 33, 908–923. [Google Scholar] [CrossRef]
- Wolokster, N.; Yazbek, G.; Ribas Milanez de Campos, J.; Munia, M.A.; Kauffman, P.; Biscegli Jatene, F.; Puech-Leao, P. Quality of life before surgery is a predictive factor for satisfaction among patients undergoing sympathectomy to treat hyperhidrosis. J. Vasc. Surg. 2010, 51, 1190–1194. [Google Scholar]
- Ho, Y.L.; Jamaluddin, M.F.; Krishinan, S.; Kareem, B.A.A. Diagnosis, impact and management of hyperhidrosis including endoscopic thoracic sympathectomy. Med. J. Malays. 2020, 75, 555–560. [Google Scholar]
- Kisielnicka, A.; Szczerkowska-Dobosz, A.; Purzycka-Bohdan, D.; Nowicki, R.J. Hyperhidrosis: Disease aetiology, classification and management in the light of modern treatment modalities. Adv. Dermatol. Allergol. 2022, 39, 251–257. [Google Scholar] [CrossRef] [PubMed]
- Nawrocki, S. Diagnosis and qualitative identification of hyperhidrosis. Shanghai Chest 2019, 3, 35. [Google Scholar] [CrossRef]
- Anghel, L.; Manole, C.; Nechita, A.; Tatu, A.L.; Stefanescu, B.; Nechita, L.; Busila, C.; Zainea, P.; Baroiu, L.; Musat, C.L. Calcium, Phosphorus and Magnesium Abnormalities Associated with COVID-19 Infection, and Beyond. Biomedicines 2023, 11, 2362. [Google Scholar] [CrossRef] [PubMed]
- Baroiu, L.; Lese, A.C.; Stefanopol, I.A.; Iancu, A.; Dumitru, C.; Ciubara, A.B.; Bujoreanu, F.C.; Baroiu, N.; Ciubara, A.; Nechifor, A.; et al. The Role of D-Dimers in the Initial Evaluation of COVID-19. Ther. Clin. Risk Manag. 2022, 18, 323–335. [Google Scholar] [CrossRef] [PubMed]
- Tatu, A.L.; Nadasdy, T.; Nwabudike, L.C. New data about sexually transmitted COVID-19. Dermatol. Ther. 2020, 33, e14426. [Google Scholar] [CrossRef] [PubMed]
- Niculet, E.; Chioncel, V.; Elisei, A.M.; Miulescu, M.; Buzia, O.D.; Nwabudike, L.C.; Craescu, M.; Draganescu, M.; Bujoreanu, F.; Marinescu, E.; et al. Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its blockade (Review). Exp. Ther. Med. 2021, 21, 263. [Google Scholar] [CrossRef] [PubMed]
- Poudel, A.N.; Zhu, S.; Cooper, N.; Roderick, P.; Alwan, N.; Tarrant, C.; Ziauddeen, N.; Yao, G.L. Impact of COVID-19 on health-related quality of life of patients: A structured review. PLoS ONE 2021, 16, e0259164. [Google Scholar] [CrossRef] [PubMed]
- Woo, W.; Oh, J.; Kim, B.J.; Won, J.; Moon, D.H.; Lee, S. The Impact of COVID-19 on Hyperhidrosis Patients in the Mental Health and Quality of Life: AWeb-Based Surveillance Study. J. Clin. Med. 2022, 11, 3576. [Google Scholar] [CrossRef]
- Nastase, F.; Verenca, M.C.; Niculet, E.; Radaschin, D.S.; Busila, C.; Vasile, C.I.; Tatu, A.L. Primary Hyperhidrosis in Children—A Retrospective Study and a Short Review. Life 2024, 14, 645. [Google Scholar] [CrossRef]
- Ravens-Sieberer, U.; Kaman, A.; Erhart, M.; Devine, J.; Schlack, R.; Otto, C. Impact of the COVID-19 pandemic on quality of life and mental health in children and adolescents in Germany. Eur. Child. Adolesc. Psychiatry. 2022, 31, 879–889. [Google Scholar] [CrossRef] [PubMed]
- Tatu, A.L.; Nadasdy, T.; Bujoreanu, F.C. Familial clustering of COVID-19 skin manifestations. Dermatol. Ther. 2020, 33, e14181. [Google Scholar] [CrossRef] [PubMed]
Year | n = 111 (%) | Girls (%) | Boys (%) | ||||
---|---|---|---|---|---|---|---|
n (%) | Age | n (%) | Age | ||||
Mean ± SD | Min.–Max. | Mean ± SD | Min.–Max. | ||||
2014 | 18 (16.22%) | 15 (83.33%) | 11.20 ± 3.36 | 6-17 | 3 (16.67%) | 10 ± 4.35 | 7–15 |
2015 | 18 (16.22%) | 12 (66.67%) | 10.83 ± 2.51 | 7–14 | 6 (33.33%) | 10.66 ± 2.16 | 8–14 |
2016 | 9 (8.11%) | 4 (44.44%) | 10.25 ± 2.62 | 8–14 | 5 (55.56%) | 10 ± 3.67 | 7–14 |
2017 | 18 (16.22%) | 9 (50%) | 11.22 ± 3.99 | 6–17 | 9 (50%) | 11.33 ± 2.55 | 9–14 |
2018 | 12 (10.81%) | 5 (41.67%) | 10.6 ± 2.60 | 9–15 | 7 (58.33%) | 10.71 ± 2.69 | 8–15 |
2019 | 12 (10.81%) | 6 (50%) | 9.66 ± 3.77 | 7–17 | 6 (50%) | 9.83 ± 3.65 | 7–15 |
2020 | 0 (0%) | 0 (0%) | 0 | 0 | 0 (0%) | 0 | 0 |
2021 | 2 (1.80%) | 2 (100%) | 11.5 ± 3.53 | 9–14 | 0 (0%) | 0 | 0 |
2022 | 0 (%) | 0 (0%) | 0 | 0 | 0 (0%) | 0 | 0 |
2023 | 22 (19.81%) | 14 (63.64%) | 10.28 ± 2.36 | 6–14 | 8 (36.36%) | 9.62 ± 2.44 | 7–14 |
Year | n = 180 (%) | Girls (%) | Boys (%) | ||||
---|---|---|---|---|---|---|---|
n (%) | Age | n (%) | Age | ||||
Mean ± SD | Min.–Max. | Mean ± SD | Min.–Max. | ||||
2014 | 28 (15.56%) | 15 (53.57%) | 11.73 ± 3.45 | 7–17 | 13 (46.43%) | 11.46 ± 4.12 | 7–16 |
2015 | 25 (13.89%) | 14 (56%) | 10.78 ± 3.46 | 7–17 | 11 (44%) | 10 ± 2.79 | 7–16 |
2016 | 23 (12.78%) | 12 (52.17%) | 12.75 ± 2.63 | 8–16 | 11 (47.83%) | 11.18 ± 2.89 | 7–16 |
2017 | 24 (13.33%) | 13 (54.16%) | 11.15 ± 3.46 | 6–16 | 11 (45.84%) | 11.63 ± 2.80 | 7–16 |
2018 | 21 (11.67%) | 12 (57.14%) | 11.75 ± 2.66 | 8–16 | 9 (42.86%) | 10.33 ± 2.54 | 7–15 |
2019 | 25 (13.89%) | 13 (52%) | 13.07 ± 3.27 | 7–17 | 12 (48%) | 11 ± 3.51 | 7–16 |
2020 | 0 (0%) | 0 (0%) | 0 | 0 | 0 (0%) | 0 | 0 |
2021 | 2 (1.11%) | 1 (50%) | 16 | 16 | 1 (50%) | 14 | 14 |
2022 | 6 (3.33%) | 4 (66,67%) | 12.25 ± 2.25 | 9–15 | 2 (33.33%) | 13.5 ± 3.53 | 11–16 |
2023 | 26 (14.44%) | 15 (57.69%) | 11.46 ± 2.92 | 7–17 | 11 (42.31%) | 11.72 ± 3.06 | 7–17 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nastase, F.; Nicolescu, A.C.; Busila, C.; Marin, C.M.; Bogdan Goroftei, E.R.; Bogdan, M.P.; Verenca, M.C.; Barbu, R.E.; Tatu, A.L. The Influence of the COVID-19 Pandemic on the Addressability to Treatment of Children with Hyperhidrosis—A Retrospective Study and a Short Review. Life 2024, 14, 995. https://doi.org/10.3390/life14080995
Nastase F, Nicolescu AC, Busila C, Marin CM, Bogdan Goroftei ER, Bogdan MP, Verenca MC, Barbu RE, Tatu AL. The Influence of the COVID-19 Pandemic on the Addressability to Treatment of Children with Hyperhidrosis—A Retrospective Study and a Short Review. Life. 2024; 14(8):995. https://doi.org/10.3390/life14080995
Chicago/Turabian StyleNastase, Florentina, Alin Codrut Nicolescu, Camelia Busila, Cristina Mihaela Marin, Elena Roxana Bogdan Goroftei, Mircea Pompiliu Bogdan, Madalina Codruta Verenca, Raisa Eloise Barbu, and Alin Laurentiu Tatu. 2024. "The Influence of the COVID-19 Pandemic on the Addressability to Treatment of Children with Hyperhidrosis—A Retrospective Study and a Short Review" Life 14, no. 8: 995. https://doi.org/10.3390/life14080995